スポンサーリンク
富山大学附属病院 神経内科 | 論文
- PJ-012 Electrophysiological and Anatomical Differences in Retrograde Slow Pathway between Fast-slow and Slow-slow Form of Atypical Atrioventricular Nodal Reentry(PJ002,Atrial/Supraventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Japan
- OE-125 Effects of Bepridil on Repolarization Dynamics and Ventricular Fibrillation in Patients with Brugada Syndrome(OE21,ECG/Body Surface Potential Mapping/Holter 2 (A),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circul
- PE-143 Usefulness of Combination Therapy with Bepridil and Amiodarone for Drug-Refractory Atrial Fibrillation in Patients with and without Left Ventricular Dysfunction(Arrhythmia, therapy(07)(A),Poster Session(English),The 72nd Annual Scientific Meeting o
- PJ-489 Dissociated Parasympathetic and Sympathetic Control of Arterial Baroreflex in Patients with Chronic Heart Failure(Heart failure, clinical-13, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- 心原性脳塞栓症 (脳卒中のすべて) -- (脳卒中の病態と種類)
- PJ-878 The Estimation of Sleep Quality in Patients with Cardiac Dysfunction Using Ultradian Rhythm of Heart Rate Variability(Heart failure, clinical(21)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) : Digest Version
- 診断の指針・治療の指針 急性期脳梗塞の内科的治療
- 就任講演 脳梗塞急性期の病態と治療--白質と内在性保護機構からの検討
- 脳卒中治療ガイドライン2004発表前後における急性期脳梗塞診療実態の比較 : 富山県における多施設共同調査
- UGT2B7^*3はR-, S-カルベジロールの体内動態に影響を及ぼさない
- その他のめまい症 (患者さんの背景・病態で考える 薬の選び方・使い方のエッセンス) -- (神経)
- 心原性脳塞栓 心原性脳塞栓症の病因と臨床像 (インターベンション時代の脳卒中学(改訂第2版)(下)超急性期から再発予防まで) -- (脳梗塞)
- イコサペント酸エチル(EPA)の有用性 (特集 脂質異常症診療のエビデンスと将来展望) -- (脂質異常症の治療薬--エビデンスと選択基凖)
- めまい (特大号 初診で必要な画像診断のすべて) -- (症候別初診で必要な画像診断)
- Is Nitric Oxide Really Important for Regulation of the Cerebral Circulation? Yes or No?
- Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation : The J-RHYTHM Registry study design
- Synergistic Effect of Combined HMG-CoA Reductase Inhibitor and Angiotensin-II Receptor Blocker Therapy in Patients With Chronic Heart Failure : The HF-COSTAR Trial
- Present Status of Anticoagulation Treatment in Japanese Patients With Atrial Fibrillation : A Report From the J-RHYTHM Registry
- Antithrombotic Therapy in Atrial Fibrillation : Evaluation and Positioning of New Oral Anticoagulant Agents
スポンサーリンク